ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	7/46	79/7206	5.51802622521e-07
ko04921	Oxytocin signaling pathway	10/46	209/7206	5.56106294215e-07
ko04260	Cardiac muscle contraction	7/46	98/7206	2.40538378269e-06
ko04020	Calcium signaling pathway	9/46	265/7206	3.58046488108e-05
ko05410	Hypertrophic cardiomyopathy (HCM)	6/46	100/7206	3.67226324339e-05
ko04261	Adrenergic signaling in cardiomyocytes	8/46	205/7206	3.85254393296e-05
ko04022	cGMP-PKG signaling pathway	7/46	216/7206	0.000390237410433
ko05414	Dilated cardiomyopathy	5/46	112/7206	0.000684145284908
ko04371	Apelin signaling pathway	6/46	177/7206	0.000835721735586
ko04010	MAPK signaling pathway	8/46	321/7206	0.000841721517511
ko05416	Viral myocarditis	3/46	55/7206	0.00506490479697
ko04270	Vascular smooth muscle contraction	4/46	154/7206	0.0163234956788
ko04970	Salivary secretion	3/46	95/7206	0.0223906160332
ko04910	Insulin signaling pathway	4/46	172/7206	0.023479402505
ko04971	Gastric acid secretion	3/46	98/7206	0.0242811036683
ko04810	Regulation of actin cytoskeleton	5/46	264/7206	0.0255865663414
ko04960	Aldosterone-regulated sodium reabsorption	2/46	41/7206	0.0279186921092
ko04973	Carbohydrate digestion and absorption	2/46	42/7206	0.0291972154384
ko04930	Type II diabetes mellitus	2/46	54/7206	0.0462511871815
ko04922	Glucagon signaling pathway	3/46	128/7206	0.0477847407372